Nonalcoholic steatohepatitis Trials in Austin, United States
Conditions / Nonalcoholic steatohepatitis / Austin, United States
Clinical trials for Nonalcoholic steatohepatitis investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03486899 | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis | COMPLETED | PHASE2 |
| NCT04971785 | Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | COMPLETED | PHASE2 |
| NCT05877547 | A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) | COMPLETED | PHASE2 |
| NCT05809934 | A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | COMPLETED | PHASE2 |
| NCT03449446 | Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | COMPLETED | PHASE2 |
| NCT03486912 | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis | COMPLETED | PHASE2 |
| NCT03248882 | Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) | COMPLETED | PHASE2 |
| NCT05011305 | Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis | COMPLETED | PHASE2 |
| NCT03053063 | Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | TERMINATED | PHASE3 |
| NCT03053050 | Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis | TERMINATED | PHASE3 |